These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 36351215)

  • 1. Nonlinear Effects in Asymmetric Catalysis by Design: Concept, Synthesis, and Applications.
    Mayer LC; Heitsch S; Trapp O
    Acc Chem Res; 2022 Dec; 55(23):3345-3361. PubMed ID: 36351215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temperature-controlled bidirectional enantioselectivity in a dynamic catalyst for asymmetric hydrogenation.
    Storch G; Trapp O
    Angew Chem Int Ed Engl; 2015 Mar; 54(12):3580-6. PubMed ID: 25708097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling the Enantioselectivity in an Adaptable Ligand by Biomimetic Intramolecular Interlocking.
    Menke JM; Trapp O
    J Org Chem; 2022 Aug; 87(16):11165-11171. PubMed ID: 35939525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steering Asymmetric Lewis Acid Catalysis Exclusively with Octahedral Metal-Centered Chirality.
    Zhang L; Meggers E
    Acc Chem Res; 2017 Feb; 50(2):320-330. PubMed ID: 28128920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. By-design enantioselective self-amplification based on non-covalent product-catalyst interactions.
    Storch G; Trapp O
    Nat Chem; 2017 Feb; 9(2):179-187. PubMed ID: 28282051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chiral-at-Ruthenium Catalysts for Nitrene-Mediated Asymmetric C-H Functionalizations.
    Ye CX; Meggers E
    Acc Chem Res; 2023 May; 56(9):1128-1141. PubMed ID: 37071874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, and Application of Chiral Bicyclic Imidazole Catalysts.
    Wang M; Zhang Z; Zhang W
    Acc Chem Res; 2022 Sep; 55(18):2708-2727. PubMed ID: 36043467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chiral metallocycles: rational synthesis and novel applications.
    Lee SJ; Lin W
    Acc Chem Res; 2008 Apr; 41(4):521-37. PubMed ID: 18271561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic asymmetric organozinc additions to carbonyl compounds.
    Pu L; Yu HB
    Chem Rev; 2001 Mar; 101(3):757-824. PubMed ID: 11712502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organocatalytic Atroposelective Synthesis of Indole Derivatives Bearing Axial Chirality: Strategies and Applications.
    Zhang HH; Shi F
    Acc Chem Res; 2022 Sep; 55(18):2562-2580. PubMed ID: 36053083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantiomer-selective activation of racemic catalysts.
    Mikami K; Terada M; Korenaga T; Matsumoto Y; Matsukawa S
    Acc Chem Res; 2000 Jun; 33(6):391-401. PubMed ID: 10891057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chiral N,N'-dioxides: new ligands and organocatalysts for catalytic asymmetric reactions.
    Liu X; Lin L; Feng X
    Acc Chem Res; 2011 Aug; 44(8):574-87. PubMed ID: 21702458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chiral Cyclopentadienyls: Enabling Ligands for Asymmetric Rh(III)-Catalyzed C-H Functionalizations.
    Ye B; Cramer N
    Acc Chem Res; 2015 May; 48(5):1308-18. PubMed ID: 25884306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chiral diphosphine and monodentate phosphorus ligands on a spiro scaffold for transition-metal-catalyzed asymmetric reactions.
    Xie JH; Zhou QL
    Acc Chem Res; 2008 May; 41(5):581-93. PubMed ID: 18311931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in asymmetric bifunctional catalysis using multimetallic systems.
    Shibasaki M; Kanai M; Matsunaga S; Kumagai N
    Acc Chem Res; 2009 Aug; 42(8):1117-27. PubMed ID: 19435320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric Activation.
    Mikami K; Terada M; Korenaga T; Matsumoto Y; Ueki M; Angelaud R
    Angew Chem Int Ed Engl; 2000 Oct; 39(20):3532-3556. PubMed ID: 11091405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Discovery of Multifunctional Chiral P Ligands for the Catalytic Construction of Quaternary Carbon/Silicon and Multiple Stereogenic Centers.
    Ye F; Xu Z; Xu LW
    Acc Chem Res; 2021 Jan; 54(2):452-470. PubMed ID: 33375791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselective "organocatalysis in disguise" by the ligand sphere of chiral metal-templated complexes.
    Larionov VA; Feringa BL; Belokon YN
    Chem Soc Rev; 2021 Sep; 50(17):9715-9740. PubMed ID: 34259242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of Axially Chiral Compounds via Asymmetric Organocatalysis.
    Wang YB; Tan B
    Acc Chem Res; 2018 Feb; 51(2):534-547. PubMed ID: 29419282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-Based Catalysts Reach the Outer Sphere through Remote Desymmetrization and Atroposelectivity.
    Metrano AJ; Miller SJ
    Acc Chem Res; 2019 Jan; 52(1):199-215. PubMed ID: 30525436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.